Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,173

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society

Open access
Zoeller, R. Thomas, Brown, T. R., Doan, L. L., Gore, A. C., Skakkebaek, N. E., Soto, A. M., Woodruff, T. J., Vom Saal, F. S.·2012·Endocrinology

Abstract

An endocrine-disrupting chemical (EDC) is an exogenous chemical, or mixture of chemicals, that can interfere with any aspect of hormone action. The potential for deleterious effects of EDC must be considered relative to the regulation of hormone synthesis, secretion, and actions and the variability in regulation of these events across the life cycle. The developmental age at which EDC exposures occur is a critical consideration in understanding their effects. Because endocrine systems exhibit tissue-, cell-, and receptor-specific actions during the life cycle, EDC can produce complex, mosaic effects. This complexity causes difficulty when a static approach to toxicity through endocrine mechanisms driven by rigid guidelines is used to identify EDC and manage risk to human and wildlife populations. We propose that principles taken from fundamental endocrinology be employed to identify EDC and manage their risk to exposed populations. We emphasize the importance of developmental stage and, in particular, the realization that exposure to a presumptive “safe” dose of chemical may impact a life stage when there is normally no endogenous hormone exposure, thereby underscoring the potential for very low-dose EDC exposures to have potent and irreversible effects. Finally, with regard to the current program designed to detect putative EDC, namely, the Endocrine Disruptor Screening Program, we offer recommendations for strengthening this program through the incorporation of basic endocrine principles to promote further understanding of complex EDC effects, especially due to developmental exposures.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/en.2012-1422

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 64

  1. Diamanti-Kandarakis, 2009, Endocrine-disrupting chemicals: an Endocrine Society scientific statement., Endocr Rev, 30, 293, 10.1210/er.2009-0002 · DOI · Paper page
  2. Kavlock, 1996, Research needs for the risk assessment of health and environmental effect of endocrine disruptors: a report of the USEPA-sponsored workshop., Environ Health Perspect, 104, 715
  3. Commission, 1996, European workshop on the impact of endocrine disruptors on human health and wildlife
  4. Putzrath, 1999, Fundamentals of health risk assessment. Use, derivation, validity and limitations of safety indices., Risk Anal, 19, 231, 10.1111/j.1539-6924.1999.tb00402.x · doi:10.1111/j.1539-6924.1999.tb00402.x
  5. Borgert, 2011, Evaluation of EPA's Tier 1 endocrine screening battery and recommendations for improving the interpretation of screening results., Regul Toxicol Pharmacol, 59, 397, 10.1016/j.yrtph.2011.01.003 · DOI
  6. Kovacs, 2012, Textbook of endocrine physiology
  7. Charlton, 2009, Agonist efficacy and receptor desensitization: from partial truths to a fuller picture., Br J Pharmacol, 158, 165, 10.1111/j.1476-5381.2009.00352.x · DOI
  8. Jeyakumar, 2011, Exploration of dimensions of estrogen potency: parsing ligand binding and coactivator binding affinities., J Biol Chem, 286, 12971, 10.1074/jbc.M110.205112 · DOI · Paper page
  9. Welshons, 2003, Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity., Environ Health Perspect, 111, 994, 10.1289/ehp.5494 · DOI · Paper page
  10. Sheehan, 2006, No-threshold dose-response curves for nongenotoxic chemicals: findings and applications for risk assessment., Environ Res, 100, 93, 10.1016/j.envres.2005.09.002 · DOI
  11. Sheehan, 1999, No threshold dose for estradiol-induced sex reversal of turtle embryos: how little is too much?, Environ Health Perspect, 107, 155, 10.1289/ehp.99107155 · DOI
  12. Melzer, 2012, Urinary bisphenol: a concentration and risk of future coronary artery disease in apparently healthy men and women, Circulation, 10.1161/CIRCULATIONAHA.111.069153 · DOI · Paper page
  13. Murashima, 2011, Essential roles of androgen signaling in Wolffian duct stabilization and epididymal cell differentiation., Endocrinology, 152, 1640, 10.1210/en.2010-1121 · DOI
  14. Renfree, 2009, Wolffian duct differentiation by physiological concentrations of androgen delivered systemically., Dev Biol, 334, 429, 10.1016/j.ydbio.2009.07.040 · DOI
  15. Welsh, 2007, The critical time window for androgen-dependent development of the Wolffian duct in the rat., Endocrinology, 148, 3185, 10.1210/en.2007-0028 · DOI
  16. Jasuja, 2009, Kinetic and thermodynamic characterization of dihydrotestosterone-induced conformational perturbations in androgen receptor ligand-binding domain., Mol Endocrinol, 23, 1231, 10.1210/me.2008-0304 · DOI
  17. Arase, 2011, Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus., Biol Reprod, 84, 734, 10.1095/biolreprod.110.087502 · DOI
  18. Whorwood, 1993, Licorice inhibits 11β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action., Endocrinology, 132, 2287, 10.1210/endo.132.6.8504732 · doi:10.1210/endo.132.6.8504732 · Paper page
  19. Veurink, 2005, The history of DES, lessons to be learned., Pharm World Sci, 27, 139, 10.1007/s11096-005-3663-z · DOI
  20. Walker, 2011, Transgenerational neuroendocrine disruption of reproduction., Nat Rev Endocrinol, 7, 197, 10.1038/nrendo.2010.215 · DOI · Paper page
  21. Gore, 2010, Neuroendocrine disruption: historical roots, current progress, questions for the future., Front Neuroendocrinol, 31, 395, 10.1016/j.yfrne.2010.07.003 · DOI
  22. Skinner, 2008, Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior., PLoS One, 3, e3745, 10.1371/journal.pone.0003745 · DOI · Paper page
  23. Ibhazehiebo, 2011, Disruption of thyroid hormone receptor-mediated transcription and thyroid hormone-induced Purkinje cell dendrite arborization by polybrominated diphenyl ethers., Environ Health Perspect, 119, 168, 10.1289/ehp.1002065 · DOI
  24. Miyazaki, 2008, Identification of the functional domain of thyroid hormone receptor responsible for polychlorinated biphenyl-mediated suppression of its action in vitro., Environ Health Perspect, 116, 1231, 10.1289/ehp.11176 · DOI
  25. McKinney, 1998, Molecular determinants of hormone mimicry: halogenated aromatic hydrocarbon environmental agents., J Toxicol Environ Health B Crit Rev, 1, 27, 10.1080/10937409809524542 · DOI
  26. Shioda, 2006, Importance of dosage standardization for interpreting transcriptomal signature profiles: evidence from studies of xenoestrogens., Proc Natl Acad Sci USA, 103, 12033, 10.1073/pnas.0605341103 · DOI
  27. vom Saal, 2006, Large effects from small exposures. II. The importance of positive controls in low-dose research on bisphenol A., Environ Res, 100, 50, 10.1016/j.envres.2005.09.001 · DOI · Paper page
  28. Knudsen, 2011, Developmental toxicity testing for safety assessment: new approaches and technologies., Birth Defects Res B Dev Reprod Toxicol, 92, 413, 10.1002/bdrb.20315 · DOI
  29. De Wever, 2012, Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation, Toxicol In Vitro, 10.1016/j.tiv.2012.01.009 · doi:10.1016/j.tiv.2012.01.009
  30. Borrell, 2010, Toxicology: the big test for bisphenol A., Nature, 464, 1122, 10.1038/4641122a · DOI
  31. Hood, 1999, Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy., Toxicol Appl Pharmacol, 160, 163, 10.1006/taap.1999.8752 · doi:10.1006/taap.1999.8752
  32. Erickson, 2001, PCB properties, uses, occurrence, and regulatory history, xii
  33. Klaassen, 2001, Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism., Toxicol Pathol, 29, 34, 10.1080/019262301301418838 · DOI
  34. Giera, 2011, Individual polychlorinated biphenyl (PCB) congeners produce tissue- and gene-specific effects on thyroid hormone signaling during development., Endocrinology, 152, 2909, 10.1210/en.2010-1490 · DOI
  35. Amano, 2010, The effect of hydroxylated polychlorinated biphenyl (OH-PCB) on thyroid hormone receptor (TR)-mediated transcription through native-thyroid hormone response element (TRE)., Ind Health, 48, 115, 10.2486/indhealth.48.115 · DOI
  36. Langer, 2009, Multiple adverse thyroid and metabolic health signs in the population from the area heavily polluted by organochlorine cocktail (PCB, DDE, HCB, dioxin)., Thyroid Res, 2, 3, 10.1186/1756-6614-2-3 · DOI
  37. You, 2006, 4-Hydroxy-PCB106 acts as a direct thyroid hormone receptor agonist in rat GH3 cells., Mol Cell Endocrinol, 257–258, 26, 10.1016/j.mce.2006.06.009 · DOI
  38. Gilbert, 2011, Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences, Neurotoxicology, 10.1016/j.ntt.2011.05.042 · doi:10.1016/j.ntt.2011.05.042
  39. Zoeller, 2007, Current and potential rodent screens and tests for thyroid toxicants., Crit Rev Toxicol, 37, 55, 10.1080/10408440601123461 · DOI
  40. Lyche, 2009, Reproductive and developmental toxicity of phthalates., J Toxicol Environ Health B Crit Rev, 12, 225, 10.1080/10937400903094091 · DOI · Paper page
  41. Kamrin, 2009, Phthalate risks, phthalate regulation, and public health: a review., J Toxicol Environ Health B Crit Rev, 12, 157, 10.1080/10937400902729226 · DOI · Paper page
  42. Gray, 2009, Transgenerational effects of Di (2-ethylhexyl) phthalate in the male CRL:CD(SD) rat: added value of assessing multiple offspring per litter., Toxicol Sci, 110, 411, 10.1093/toxsci/kfp109 · DOI
  43. Foster, 2006, Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters., Int J Androl, 29, 140, 10.1111/j.1365-2605.2005.00563.x · DOI · Paper page
  44. Noriega, 2009, Pubertal administration of DEHP delays puberty, suppresses testosterone production, and inhibits reproductive tract development in male Sprague-Dawley and Long-Evans rats., Toxicol Sci, 111, 163, 10.1093/toxsci/kfp129 · DOI
  45. Kurata, 2012, Metabolism of di (2-ethylhexyl) phthalate (DEHP): comparative study in juvenile and fetal marmosets and rats., J Toxicol Sci, 37, 33, 10.2131/jts.37.33 · DOI
  46. Rajapakse, 2002, Combining xenoestrogens at levels below individual no-observed-effect concentrations dramatically enhances steroid hormone action., Environ Health Perspect, 110, 917, 10.1289/ehp.02110917 · DOI · Paper page
  47. Watson, 2010, Nongenomic signaling pathways of estrogen toxicity., Toxicol Sci, 115, 1, 10.1093/toxsci/kfp288 · DOI
  48. Welshons, 2006, Large effects from small exposures. III. Endocrine mechanisms mediating effects of bisphenol A at levels of human exposure., Endocrinology, 147, S56, 10.1210/en.2005-1159 · DOI · Paper page
  49. Alonso-Magdalena, 2008, A pancreatic insulin content regulation by the estrogen receptor ERα., PLoS One, 3, e2069, 10.1371/journal.pone.0002069 · DOI · Paper page
  50. Soriano, 2012, A rapid insulinotropic action of low doses of bisphenol-A on mouse and human islets of Langerhans: role of estrogen receptor β., PLoS One, 7, e31109, 10.1371/journal.pone.0031109 · DOI · Paper page
  51. Alonso-Magdalena, 2010, Bisphenol A exposure during pregnancy disrupts glucose homeostasis in mothers and adult male offspring., Environ Health Perspect, 118, 1243, 10.1289/ehp.1001993 · DOI · Paper page
  52. Jenkins, 2011, Chronic oral exposure to bisphenol A results in a nonmonotonic dose response in mammary carcinogenesis and metastasis in MMTV-erbB2 mice., Environ Health Perspect, 119, 1604, 10.1289/ehp.1103850 · DOI · Paper page
  53. LaPensee, 2010, Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy., Endocr Relat Cancer, 17, R91, 10.1677/ERC-09-0253 · DOI
  54. Soto, 2008, Does breast cancer start in the womb?, Basic Clin Pharmacol, 102, 125, 10.1111/j.1742-7843.2007.00165.x · DOI
  55. Murray, 2007, Induction of mammary gland ductal hyperplasias and carcinoma in situ following fetal bisphenol A exposure., Reprod Toxicol, 23, 383, 10.1016/j.reprotox.2006.10.002 · DOI · Paper page
  56. Durando, 2007, Prenatal bisphenol A exposure induces preneoplastic lesions in the mammary gland in Wistar rats., Environ Health Perspect, 115, 80, 10.1289/ehp.9282 · DOI · Paper page
  57. Betancourt, 2010, In utero exposure to bisphenol A shifts the window of susceptibility for mammary carcinogenesis in the rat., Environ Health Perspect, 118, 1614, 10.1289/ehp.1002148 · DOI
  58. Jenkins, 2009, Oral exposure to bisphenol a increases dimethylbenzanthracene-induced mammary cancer in rats., Environ Health Perspect, 117, 910, 10.1289/ehp.11751 · DOI · Paper page
  59. Lake, 1995, Comparisons of patterns of polychlorinated biphenyl congeners in water, sediment, and indigenous organisms from New Bedford Harbor, Massachusetts., Arch Environ Contam Toxicol, 29, 207, 10.1007/BF00212972 · doi:10.1007/bf00212972
  60. McFarland, 1989, Environmental occurrence, abundance, and potential toxicity of polychlorinated biphenyl congeners: considerations for a congener-specific analysis., Environ Health Perspect, 81, 225, 10.1289/ehp.8981225 · DOI · Paper page
  61. Quinn, 2011, Investigating intergenerational differences in human PCB exposure due to variable emissions and reproductive behaviors., Environ Health Perspect, 119, 641, 10.1289/ehp.1002415 · DOI
  62. Ma, 2006, PCBs exert an estrogenic effect through repression of the Wnt7a signaling pathway in the female reproductive tract., Environ Health Perspect, 114, 898, 10.1289/ehp.8748 · DOI
  63. Carpenter, 2006, Polychlorinated biphenyls (PCBs): routes of exposure and effects on human health., Rev Environ Health, 21, 1, 10.1515/REVEH.2006.21.1.1 · DOI · Paper page
  64. Welshons, 1987, Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-free) culture., Eur J Cancer Clin Oncol, 23, 1935, 10.1016/0277-5379(87)90062-9 · DOI

Cited by

See all 1,173

Metadata

Authors
Zoeller, R. T., Brown, T. R., Doan, L. L., Gore, A. C., Skakkebaek, N. E., Soto, A. M., Woodruff, T. J., & Vom Saal, F. S.
Venue
Endocrinology
Published
2012-09-01
Volume
153
Issue
9
Pages
4097-4110
ISSN
  • 0013-7227 (ISSN-L)
  • 1945-7170
OpenAlex
W2140321480
Cited by
1,173
References
5
FWCI
39.74
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society. https://app.cochat.ai/papers/10.1210/en.2012-1422
The paper
Zoeller, R. T., Brown, T. R., Doan, L. L., Gore, A. C., Skakkebaek, N. E., Soto, A. M., Woodruff, T. J., & Vom Saal, F. S. (2012). Endocrine-Disrupting Chemicals and Public Health Protection: A Statement of Principles from The Endocrine Society. Endocrinology. https://doi.org/10.1210/en.2012-1422

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.